Other grades of this product :
| CP-424,174 Basic information |
| Product Name: | CP-424,174 | | Synonyms: | CP-424,174;N-[[[4-Chloro-2,6-bis(1-methylethyl)phenyl]amino]carbonyl]-3-(1-hydroxy-1-methylethyl)benzenesulfonamide;Benzenesulfonamide, N-[[[4-chloro-2,6-bis(1-methylethyl)phenyl]amino]carbonyl]-3-(1-hydroxy-1-methylethyl)-;CP-424,174 >=98% (HPLC);N-((4-Chloro-2,6-diisopropylphenyl)carbamoyl)-3-(2-hydroxypropan-2-yl)benzenesulfonamide | | CAS: | 210825-31-3 | | MF: | C22H29ClN2O4S | | MW: | 452.99 | | EINECS: | | Product Categories: | | Mol File: | 210825-31-3.mol |
| CP-424,174 Chemical Properties |
| density | 1?+-.0.06 g/cm3(Predicted) | | storage temp. | room temp | | form | powder | | pka | 4.67±0.10(Predicted) | | color | white to beige |
| CP-424,174 Usage And Synthesis |
| Biochem/physiol Actions | CP-424,174 is a cytokine release inhibitory drugs (CRID) that inhibits the post-translational processing and secretion of IL-1b in response to LPS and ATP in human monocytes. It is quite possible that similarly to CP-456,773 (termed CRID3), CP-424,174 inhibits both NLRP3 and AIM2 inflammasomes by preventing ASC oligomerisation. |
| CP-424,174 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye